GMI is frequently used as a substitute for HbA1c, especially when using remote monitoring, and the difference between them has a clinical relevance¹. In this study, GMI and Hba1c, along with other glycemic parameters, are examined in patients with Type 1 diabetes, Type 2 diabetes (T2D), and prediabetes using the Freestyle libre sensor during hybrid (both physical and continuous remote monitoring) therapeutic care (GluCare.Health).A retrospective observational study included 45 adults who used CGM > 70 % in 3 months. Time in range (TIR), average glucose (AG), GMI, and percentage coefficient of variation (% CV) were collected from each patient's 90-day Libreview report, along with their HbA1c. Patients were monitored in-clinic and remotely through GluCare.health. HbA1c and GMI were calculated and categorized into four categories: <0.1, 0.1-0.4, 0.5-0.9, and > 1.Mean patient's age was 41.7 ± 16.8 years. HbA1c and GMI were different in 86.4 % of the patients. Significant differences in AG, TIR, %CV, HbA1c and GMI were observed among the 3 groups (p<0.001) (Table 1). Significance between categories of HbA1c - GMI across all cohorts, with T1D showing a higher proportion of variation compared to T2D and prediabetes (p = 0.034).
HbA1c-GMI can be used in immediate decision making to manage diabetes when practicing a hybrid care model that uses continuous remote monitoring together with physical visits.
M. Caccelli: None. C. Ozkan: None. H. Zakaria: None. J. Kattan: None. R. Sultan: None. Y. Said: None. A. Hashemi: None. I. Almarzooqi: None.
